This announcement is a separate document:
ステラファーマ：胸部悪性腫瘍を対象としたBNCT国内第Ｉ/ＩＩ相臨床試験の治験計画届提出のお知らせ
Stella Pharma: Announcements of individual stocks: Notification of submission of a clinical trial plan for domestic Phase I/II clinical trial of BNCT targeting malignant tumors of the chest.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.